My Blog List

Wednesday, 20 December 2017

Gastrointestinal Cancer Drug Market trends estimates high demand by 2023

Description:

In this report, the global Gastrointestinal Cancer Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Cancer Drug in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India


Global Gastrointestinal Cancer Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
GlaxoSmithKline plc.
Pfizer Inc.
Sanofi
Novartis AG.
Bristol-Myers Squibb Company
Amgen Limited & Amgen Ireland Limited
Johnson & Johnson Private Limited


On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Therapy
Immunotherapy
Chemotherapy
Targeted Therapy
Radiation Therapy
Hormone Therapy
Adjuvant Chemotherapy
By Route of Administration
Oral
Injectable Therapy
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Radiology
Oncology

Table of Contents

1 Gastrointestinal Cancer Drug Market Overview1.1 Product Overview and Scope of Gastrointestinal Cancer Drug
1.2 Gastrointestinal Cancer Drug Segment By Therapy
1.2.1 Global Gastrointestinal Cancer Drug Production and CAGR (%) Comparison By Therapy (Product Category)(2012–2022)
1.2.2 Global Gastrointestinal Cancer Drug Production Market Share By Therapy (Product Category) in 2016
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Targeted Therapy
1.2.6 Radiation Therapy
1.2.7 Hormone Therapy
1.2.8 Adjuvant Chemotherapy
1.3 Gastrointestinal Cancer Drug Segment By Route of Administration
1.3.1 Oral
1.3.2 Injectable Therapy
1.4 Global Gastrointestinal Cancer Drug Segment by Application
1.4.1 Gastrointestinal Cancer Drug Consumption (Sales) Comparison by Application (2012–2022)
1.4.2 Radiology
1.4.3 Oncology
1.5 Global Gastrointestinal Cancer Drug Market by Region (2012–2022)
1.5.1 Global Gastrointestinal Cancer Drug Market Size (Value) and CAGR (%) Comparison by Region (2012–2022)
1.5.2 North America Status and Prospect (2012–2022)
1.5.3 Europe Status and Prospect (2012–2022)
1.5.4 China Status and Prospect (2012–2022)
1.5.5 Japan Status and Prospect (2012–2022)
1.5.6 Southeast Asia Status and Prospect (2012–2022)
1.5.7 India Status and Prospect (2012–2022)
1.6 Global Market Size (Value) of Gastrointestinal Cancer Drug (2012–2022)
1.6.1 Global Gastrointestinal Cancer Drug Revenue Status and Outlook (2012–2022)
1.6.2 Global Gastrointestinal Cancer Drug Capacity, Production Status and Outlook (2012–2022)

2 Global Gastrointestinal Cancer Drug Market Competition by Manufacturers2.1 Global Gastrointestinal Cancer Drug Capacity, Production and Share by Manufacturers (2012–2017)
2.1.1 Global Gastrointestinal Cancer Drug Capacity and Share by Manufacturers (2012–2017)
2.1.2 Global Gastrointestinal Cancer Drug Production and Share by Manufacturers (2012–2017)
2.2 Global Gastrointestinal Cancer Drug Revenue and Share by Manufacturers (2012–2017)
2.3 Global Gastrointestinal Cancer Drug Average Price by Manufacturers (2012–2017)
2.4 Manufacturers Gastrointestinal Cancer Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal Cancer Drug Market Competitive Situation and Trends
2.5.1 Gastrointestinal Cancer Drug Market Concentration Rate
2.5.2 Gastrointestinal Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Gastrointestinal Cancer Drug Capacity, Production, Revenue (Value) by Region (2012–2017)3.1 Global Gastrointestinal Cancer Drug Capacity and Market Share by Region (2012–2017)
3.2 Global Gastrointestinal Cancer Drug Production and Market Share by Region (2012–2017)
3.3 Global Gastrointestinal Cancer Drug Revenue (Value) and Market Share by Region (2012–2017)
3.4 Global Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.5 North America Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.6 Europe Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.7 China Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.8 Japan Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.9 Southeast Asia Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.10 India Gastrointestinal Cancer Drug Capacity, Production, Revenue, Price and Gross Margin (2012–2017)

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India